shutterstock_1463056853.jpg

MEDSIR-LED CLINICAL TRIALS UNITE SCIENTIFIC EXCELLENCE, PATIENT FOCUS AND STRATEGIC THINKING. MEDSIR MANAGEMENT MODEL ENSURES SPEED, RELIABILITY AND THE STREAMLINING OF CLINICAL DEVELOPMENT PLANS.

SMART STUDY DESIGNS FOR STRATEGIC CLINICAL TRIALS

PUBLICATIONS

Publications

THE ULTIMATE GOAL OF MEDSIR PROJECTS IS THE PUBLICATION OF ITS STUDY RESULTS, WHETHER IN PEER-REVIEWED JOURNALS OR AT A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES IN THE FORM OF ABSTRACTS, POSTERS, OR ORAL PRESENTATIONS.

ABSTRACT (Posters, presentations, etc.)

YEAR

CONGRESS/

JOURNAL

PROJECT

REVERT

A multicenter, randomized, phase II trial evaluating the efficacy of eribulin monotherapy and eribulin plus endocrine therapy in locally-recurrent or metastatic breast cancer patients after progression on endocrine therapy (REVERT).

download.png

ESMO

2022

PECATI

Abemaciclib with endocrine therapy ± paclitaxel in aggressive ER+/HER2- advanced breast cancer

download.png

ESMO

2022

COPÉRNICO

Tocilizumab with pembrolizumab for treatment of COVID-19 pneumonia in patients unresponsive to standard care

download.png

International Journal of Infectious Disease

2022

EXACAAPE

Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial

download.png

European Journal of Cancer

2022

DEBBRAH

Trastuzumab deruxtecan in HER2+ advance breast cancer with brain mets and/or leptomeningeal carcinomatosis

download.png

Neuro-Oncology Journal

2022

Other MEDSIR related articles

home_fondo_cuadritos2.jpg
"
WE TURN THE BEST CLINICAL RESEARCH IDEAS INTO A BRIGHTER FUTURE FOR CANCER PATIENTS.